Atara Biotherapeutics (NASDAQ:ATRA) commences public offering of 3M shares of common stock. Underwriters over-allotment is an additional 450K shares. Terms and pricing have yet to be announced.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.